About Pierre A. MORGON

Pierre A. MORGON is Chief Executive Officer of AJ Biologics and Regional Partner for Switzerland at Mérieux Développement. He is also Non-Executive Director to the Board of Theradiag since March 2012, a company focusing on in vitro diagnostics in auto-immunity, infectious diseases and allergy, as well as Non-Executive Director to the Board of Eurocine Vaccines since December 2013, a company dedica...

Pierre A. MORGON is Chief Executive Officer of AJ Biologics and Regional Partner for Switzerland at Mérieux Développement. He is also Non-Executive Director to the Board of Theradiag since March 2012, a company focusing on in vitro diagnostics in auto-immunity, infectious diseases and allergy, as well as Non-Executive Director to the Board of Eurocine Vaccines since December 2013, a company dedicated to developing nasal vaccines. He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA. He is also an alumnus of INSEAD, IMD and MCE executive programs. Pierre has over 28 years of experience in the pharmaceutical and biological industry and in healthcare IT, both in marketing positions (from product marketing at country level to global marketing strategy) and in operations (from business unit head to general manager). Through these local and global positions, he has acquired direct experience with blockbuster products in diverse markets (primary care, specialty care, hospital, vaccines, and biotechnology), geographies (US, Europe, Japan, China, India, Emerging Markets) and organizations. He spent 2 years at ICI-Pharma, followed by 8 years at Synthelabo, then a division of L’Oreal, followed by 6 years at Aventis Pasteur. Then he had diversified senior executive experiences at Yamanouchi Pharma, BMS, Drug Abuse Sciences, Schering-Plough, Bio Alliance Pharma and Sanofi Pasteur. He joined AJ Biologics from Cegedim where he was Chief Marketing Officer and member of the Executive Committee.

Contact Pierre A. MORGON